EUVIMED · CrossrefZeitschrift
Biopharmaceutics & Drug Disposition
ISSN 0142-2782 · Wiley
Neueste Artikel
A Slowly Self‐Emulsifying Delivery System of Sesamin With Improved Biopharmaceutical Properties
Corneal Targeted Mucoadhesive Emulsion for Prolonged Delivery of Voriconazole: Formulation Evaluation and Pharmacokinetic Assessment
Integration of Data‐Driven Techniques in Nanomedicines to Address Diagnosis and Drug Delivery Strategy for Therapy
Utility of cystatin C and serum creatinine‐based glomerular filtration rate equations in predicting vancomycin clearance: A population pharmacokinetics analysis in elderly Chinese patients
Coming full circle: The potential utility of real‐world evidence to discern predictions from a physiologically based pharmacokinetic model
Norvancomycin plasma concentration monitoring in hemodialysis patients with end stage kidney disease: A retrospective cohort study
The role of the efflux transporter, P‐glycoprotein, at the blood–brain barrier in drug discovery
Biodistribution and delivery of oligonucleotide therapeutics to the central nervous system: Advances, challenges, and future perspectives
In vitro and ex vivo experimental models for evaluation of intranasal systemic drug delivery as well as direct nose‐to‐brain drug delivery
Physiologically based pharmacokinetic model to predict drug concentrations of breast cancer resistance protein substrates in milk
Prediction of basic drug exposure in milk using a lactation model algorithm integrated within a physiologically based pharmacokinetic model
Effect of ABCB1 gene variants on rivaroxaban pharmacokinetic and hemorrhage events occurring in patients with non‐valvular atrial fibrillation
Evaluation on absorption risks of amentoflavone after oral administration in rats
Physiological‐based pharmacokinetic modeling trends in pharmaceutical drug development over the last 20‐years; in‐depth analysis of applications, organizations, and platforms
Effects of gut microbiota on in vivo metabolism and tissue accumulation of cytochrome P450 3A metabolized drug: Midazolam
Concomitant lansoprazole ameliorates cisplatin‐induced nephrotoxicity by inhibiting renal organic cation transporter 2 in rats
Interspecies prediction of pharmacokinetics and tissue distribution of doxorubicin by physiologically‐based pharmacokinetic modeling
Comparative pharmacokinetics and tissue distribution of cryptotanshinone, tanshinone IIA, dihydrotanshinone I, and tanshinone I after oral administration of pure tanshinones and liposoluble extract of Salvia miltiorrhiza to rats
Black tea extract and theaflavin derivatives affect the pharmacokinetics of rosuvastatin by modulating organic anion transporting polypeptide (OATP) 2B1 activity
Selective reduction in the expression of UGTs and SULTs, a novel mechanism by which piperine enhances the bioavailability of curcumin in rat
A quantitative threshold for high/low extent of urinary excretion of compounds in humans
Absorption and cleavage of enalapril, a carboxyl ester prodrug, in the rat intestine: in vitro, in situ intestinal perfusion and portal vein cannulation models
Emerging roles of metal solute carriers in cancer mechanisms and treatment
SGLT2 inhibitor lowers serum uric acid through alteration of uric acid transport activity in renal tubule by increased glycosuria
Development of physiologically based pharmacokinetic model to evaluate the relative systemic exposure to quetiapine after administration of IR and XR formulations to adults, children and adolescents
Brain microdialysate, CSF and plasma pharmacokinetics of ligustrazine hydrochloride in rats after intranasal and intravenous administration
Structure‐based prediction of human intestinal membrane permeability for rapid in silico BCS classification
Therapeutic drug monitoring and pharmacokinetic compartmental analysis of sulpiride double‐peak absorption profile after oral administration to human volunteers
Pharmacokinetics, pharmacodynamics and toxicities of methotrexate in healthy and collagen‐induced arthritic rats
A physiologically based pharmacokinetic (PBPK) approach to evaluate pharmacokinetics in patients with cancer
Jahrgänge
2026 · 132025 · 262024 · 212023 · 422022 · 322021 · 462020 · 352019 · 422018 · 572017 · 602016 · 682015 · 522014 · 492013 · 482012 · 542011 · 482010 · 422009 · 522008 · 572007 · 572006 · 502005 · 512004 · 482003 · 432002 · 542001 · 392000 · 561999 · 951998 · 1201997 · 1041996 · 1131995 · 901994 · 781993 · 861992 · 801991 · 791990 · 851989 · 651988 · 581987 · 60
EUVIMED